Understanding and assessing the impact of treatment in diabetes: The treatment-related impact measures for diabetes and devices (TRIM-Diabetes and TRIM-Diabetes Device)

Health and Quality of Life Outcomes

Volumn 7, Issue , 2009, Pages 83-

  Brod, Meryl ^a   Hammer, Mette ^b   Christensen, Torsten ^b   Lessard, Suzanne ^a   Bushnell, Donald M ^c  

^a Brod Group   (United States)

^b NOVO NORDISK A S   (Denmark)

^c Health Research Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BOTHERSOMENESS; CLINICAL ASSESSMENT TOOL; DIABETES MELLITUS; FEMALE; HEALTH CARE; HEALTH SURVEY; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PATIENT ATTITUDE; PSYCHOMETRY; QUALITY OF LIFE; TEST RETEST RELIABILITY; TREATMENT RELATED IMPACT MEASURES FOR DIABETES AND DEVICES; VALIDITY;

EID: 70449412942     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-7-83     Document Type: Article

References (19)

1. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006, 4:79. 10.1186/1477-7525-4-79, 1629006, 17034633.
2. Brod M, Skovlund SE, Wittrup-Jensen KU. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res 2006, 15(3):481-491. 10.1007/s11136-005-1624-6, 16547787.
3. Brod M, Hammer M, Christensen TL. Understanding and assessing the impact of diabetes treatment across medication delivery systems. Value in Health 2008, 11(6):A512.
4. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, Schwartz CE. Assessment of diabetes-related distress. Diabetes Care 1995, 18(6):754-760. 10.2337/diacare.18.6.754, 7555499.
5. Wild DJ, Clayson DJ, Keating K, Gondek K. Validation of a patient-administered questionnaire to measure the activity impairment experienced by women with uncomplicated urinary tract infection: the Activity Impairment Assessment (AIA). Health Qual Life Outcomes 2005, 3:42. 10.1186/1477-7525-3-42, 1180845, 16022727.
6. Anderson RT, Skovlund SE, Marrero D, Levine DW, Meadows K, Brod M, Balkrishnan R. Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther 2004, 26(4):565-578. 10.1016/S0149-2918(04)90059-8, 15189754.
7. Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004, 2:12. 10.1186/1477-7525-2-12, 398419, 14987333.
8. Anderson RT, Marrero D, Skovlund SE, Cramer J, Schwartz S. Self-reported compliance with insulin injection therapy in subjects with type 1 and 2 diabetes. Diabetes & metabolism 2003, 29:A275.
9. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993, 29(2):321-326.
10. Radloff LS. The CES-D Scale: A Self-Report Depression Scale for Research in the General Population. Applied Psychological Measurement 1977, 1(3):385-401.
11. Snoek FJ, Mollema ED, Heine RJ, Bouter LM, Ploeg HM. Development and validation of the diabetes fear of injecting and self-testing questionnaire (D-FISQ): first findings. Diabet Med 1997, 14(10):871-876. 10.1002/(SICI)1096-9136(199710)14:10<871::AID-DIA457>3.0.CO;2-Y, 9371481.
12. Hays RD, Anderson RT, Revicki DA. Assessing reliability and validity of measurement in clinical trials. Quality of Life Assessment in Clinical Trials: Methods and Practice 1998, 169-182. New York: Oxford University Press, Staquet MJ, Hays RD, Fayers PM.
13. Campbell DT, Fiske DW. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 1959, 56(2):81-105. 10.1037/h0046016, 13634291.
14. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16(3):297-334.
15. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003, 41(5):582-592. 10.1097/00005650-200305000-00004, 12719681.
16. Rideout V, Neuman T, Brodie M. e-Health and the Elderly: How seniors use the internet for health information - key findings from a national survey of older Americans. 2005, The Henry J. Kaiser Family Foundation., http://www.kff.org/entmedia/entmedia011205pkg.cfm
17. Bushnell DM, Martin ML, Parasuraman B. Electronic versus paper questionnaires: a further comparison in persons with asthma. J Asthma 2003, 40(7):751-762. 10.1081/JAS-120023501, 14626331.
18. Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value Health 2008, 11(2):322-333. 10.1111/j.1524-4733.2007.00231.x, 18380645.
19. Kleinman L, Leidy NK, Crawley J, Bonomi A, Schoenfeld P. A comparative trial of paper-and-pencil versus computer administration of the Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire. Med Care 2001, 39(2):181-189. 10.1097/00005650-200102000-00008, 11176555.